JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J. Biol. Chem., Vol. 283, Issue 27, 99932, July 4, 2008
This Article
Right arrow Full Text (PDF)
Right arrow Author Profile
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Related Collections
Right arrow Papers Of The Week
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Arresting Prostate Cancer{diamondsuit}

Many members of the Ras protein superfamily undergo a post-translational modification on their C terminus known as prenylation that is important for their overall stability and function. Considering the major role Ras proteins play in cancer, this chemical modification is also an ideal drug target. In this Paper of the Week, Mei Wang and colleagues evaluate the mechanism of one such drug called cysmethynil, a small molecule inhibitor of the enzyme isoprenylcysteine carboxylmethyltransferase (Icmt, which catalyzes the last step of the prenylation process). Using PC3 prostate cancer cells in both in vitro and in vivo models, they find that cysmethynil treatment results in an increased number of cells arrested in G1 phase and increased cell death through autophagy; these two observances were likely induced by a decrease in mTOR signaling. This dual effect of growth arrest and cell death (through a non-apoptosis pathway) makes this small molecule inhibitor a candidate for a cancer therapeutic. As evidence of its potential, Wang and colleagues demonstrated that cysmethynil treatment could markedly reduce tumor size in mouse xenograft models.Go


Figure 1
Acridine orange labeling of PC3 cells reveals that cysmethynil treatment dramatically increases the number of acidic vesicles (orange-red), a marker for autophagy.

FOOTNOTES

{diamondsuit} See referenced article, J. Biol. Chem. 2008, 283, 18678-18684 Back



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Author Profile
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Related Collections
Right arrow Papers Of The Week
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.